
About LifeMax
LifeMax is a Healthcare company based in Redwood City (United States) founded in 2014. It develops innovative therapeutic solutions for Netherton syndrome treatment. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Rare Diseases. Its competitors include Castle Creek Biosciences and Eicos Sciences; 1 of its 2 listed competitors has raised funding.
Company details
LifeMax develops innovative therapeutic solutions for netherton syndrome treatment, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and rare diseases. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Redwood City, United States
- SectorsHealthcare
- Website lifemaxlabs.com
People of LifeMax
6 people are tracked at LifeMax (6 in leadership).
| Name | Role | Group |
|---|---|---|
Larry Hsu | Chairman & CEO | Leadership |
Michael Huang | Chief Medical Officer | Leadership |
Laura Zhu | Chief Business Officer | Leadership |
Andrew Sauter | Chief Financial Officer | Leadership |
Kirk Johnson | Chief Scientific Officer | Leadership |
Dorothy Nguyen | Vp, Clinical Development | Leadership |
Complete people profiles for LifeMax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of LifeMax
LifeMax has 2 listed competitors in our database, 1 of them funded. They include Castle Creek Biosciences and Eicos Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| castlecreekbio.com | 2018 | Exton, United States | $192.8M | 41 | Gene therapy platform for rare disease treatments is developed. | |
| eicossciences.com | 2016 | San Mateo, United States | 9 | Develops Prostacyclin-based therapies for underserved medical conditions globally. |
Detailed competitors of LifeMax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Rare Diseases
3 companies that operate in the same segment as LifeMax (Rare Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lifemax
Complete news archive for LifeMax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LifeMax
LifeMax was founded in 2014.
LifeMax is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
LifeMax develops innovative therapeutic solutions for netherton syndrome treatment, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and rare diseases. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
LifeMax's top competitors include Castle Creek Biosciences and Eicos Sciences.
